Copyright © 2006, European Society of Cardiology
Enhancement of new vessel formation by Angiopoietin-2/Tie2 signaling in endothelial progenitor cells: A new hope for future therapy?
Division of Cardiology, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan
Graduate Institute of Medical Sciences, Taipei Medical University, Taipei, Taiwan
* Division of Cardiology, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan. Tel.: +886 2 2833 2211; fax: +886 2 2836 5775. Email address: shyukg@ms12.hinet.net
Received 19 September 2006; accepted 25 September 2006
| The first 10% of the full text of this article appears below. |
See article by Kim et al. [6] (pages 394–402) in this issue.
The Tie2/angiopoietin pathway is crucial for angiogenesis, blood vessel maturation, and vascular endothelial integrity. The ligands for Tie2 are the angiopoietins, of which angiopoietin-1 (Ang1) and Ang2 have been the most studied. Suppression of plasma leakage, inhibition of vascular inflammation, and prevention of endothelial death are the three widely accepted vascular protective functions for Ang1 [1], the first ligand identified for the Tie2 receptor. However, the role of Ang2, a relative of Ang1 identified by homology screening, remains less clear, because Ang2 exhibits context-dependent behavior. Ang2 can